Metacrine
Metacrine is a clinical-stage biopharmaceutical company pioneering differentiated therapies for patients with gastrointestinal (GI) and liver diseases.
1
Funding Rounds
$65.0m
Money raised
Overview
Metacrine is a clinical-stage biopharmaceutical company pioneering differentiated therapies for patients with gastrointestinal (GI) and liver diseases.
- Website:
- Business model: B2C
- Social accounts: linkedin
| Name | Phone | Social networks | |
|---|---|---|---|
| Ri***** He**** | - | - | |
| Am** Na**** | - | - | linkedin twitter |
| Ju*** C. Ow*** | - | - | - |
| Jo** Mc********* | - | - | - |
| Pr***** Kl***** | - | - | - |
| Je** Jo**** | - | - | - |
| An**** Gu******** | - | - |
Funding series
Funding Series Analysis
The company Metacrine has raised a total of $65m in funding over 1 rounds.
Key Insights:
- Metacrine Series C round, June 2018: $65m
Metacrine Series C round, June 2018
$65m
Industries
Metacrine is active in the following industries:
- Liver disease
- Technology
- Biology
- Biotechnology
- Chemistry
- Drug metabolism
- Enzyme kinetics